Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol-Myers Squibb presents new MGAT2 inhibitors

Nov. 7, 2019

Lilly opens phase I study of LY-3435151 in advanced solid tumors

Nov. 7, 2019

Retrotope initiates phase II/III study of RT-001 in Friedreich's ataxia

Nov. 7, 2019

New phase I trial explores BI-1701963 in KRAS-mutated advanced or metastatic solid tumors

Nov. 7, 2019

Boehringer Ingelheim reports data on new SOS1-KRAS interaction inhibitors for cancer

Nov. 7, 2019

Schizophrenia biomarker can be detected in human hair

Nov. 7, 2019

Sanofi Pasteur presents preclinical data for ZIKV vaccine ZPIV-SP

Nov. 7, 2019

ABSK-041, a highly potent and orally available small-molecule PD-L1 antagonist

Nov. 7, 2019

Adagene presents first-in-human data for ADG-106

Nov. 7, 2019

Early clinical data presented for AGIL-AADC gene therapy in children with AADC deficiency

Nov. 7, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...